Difference between revisions of "Team:BGIC-Union"

 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
  
 
<html>
 
<html>
 +
  <head>
 +
  <html>
 
   <head>
 
   <head>
 
     <meta charset="utf-8">
 
     <meta charset="utf-8">
Line 11: Line 13:
 
   <head>
 
   <head>
 
    
 
    
<!-- main -->
+
 
 +
  <!-- Bootstrap core CSS -->
 +
    <link href="https://2017.igem.org/Template:BGIC-Union/bootstrap-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 +
 
 +
  <!-- carousel -->
 +
  <link href="https://2017.igem.org/Template:BGIC-Union/owlcarousel-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 +
  <link href=" https://2017.igem.org/Template:BGIC-Union/fontawesomemin2-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 +
 
 +
  <!-- main -->
 
   <style type="text/css">
 
   <style type="text/css">
 
    
 
    
@import url(http://fonts.googleapis.com/css?family=Montserrat:400,700);
+
 
 
#top_title,#sideMenu { display: none !important; }
 
#top_title,#sideMenu { display: none !important; }
 
         #content {
 
         #content {
Line 23: Line 33:
 
         }
 
         }
  
 +
#bodyContent
 +
{
 +
margin-top:0px !important;
 +
}
  
#footer{
 
padding-botton:-60px;
 
}
 
  
 +
#content{
 +
  background-color: #FFe4e1; !important;
 +
}
  
  
 +
.mainstyle
 +
{
 +
font-family: Comic Sans MS;
 +
}
 +
html, body {
 +
    margin: 0 ;
 +
    padding: 0 ;
 +
}
 +
body {
 +
  background-color: #ffa07a;
 +
  margin-keft:150px
 +
    font-weight: 400;
 +
    font-size: 14px;
 +
    color: #555;
 +
    ;
 +
    -webkit-font-smoothing: antialiased;
 +
    -webkit-overflow-scrolling: touch;
 +
}
  
 +
/* Titles */
 +
h1, h2, h3, h4, h5, h6, p {
 +
font-family: Comic Sans MS;
 +
    font-weight: 700;
 +
    color: #333;
 +
}
  
top1 {
+
h1 {
padding-top: -20px;
+
font-size: 35px;
]
+
margin-top: 30px;
 +
margin-bottom: 30px;
 +
}
  
  </head>
 
  <!-- Bootstrap core CSS -->
 
    <link href="https://2017.igem.org/Template:BGIC-Union/bootstrap-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 
<!-- animate -->
 
<link href="https://2017.igem.org/Template:BGIC-Union/animate-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 
  <!-- carousel -->
 
  <link href="https://2017.igem.org/Template:BGIC-Union/owlcarousel-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 
  <link href=" https://2017.igem.org/Template:BGIC-Union/fontawesomemin2-css?action=raw&amp;ctype=text/css" rel="stylesheet">
 
  
  <!-- main -->
+
 
    <link href="https://2017.igem.org/Team:BGIC-Union/mainstyle/css?action=raw&amp;ctype=text/css" rel="stylesheet">
+
 
 +
p {
 +
    line-height: 28px;
 +
    margin-bottom: 25px;
 +
    font-size: 13px;
 +
font-family: Comic Sans MS;
 +
}
 +
 
 +
.centered {
 +
    text-align: center;
 +
}
 +
 
 +
/* Links */
 +
a {
 +
    color: #20B2AA;
 +
    word-wrap: break-word;
 +
font-size: 18px;
 +
    -webkit-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -moz-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -ms-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -o-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    transition: color 0.1s ease-in, background 0.1s ease-in;
 +
}
 +
 
 +
a:hover,
 +
a:focus {
 +
    color: #7b7b7b;
 +
    text-decoration: none;
 +
    outline: 0;
 +
}
 +
 
 +
a:before,
 +
a:after {
 +
    -webkit-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -moz-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -ms-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    -o-transition: color 0.1s ease-in, background 0.1s ease-in;
 +
    transition: color 0.1s ease-in, background 0.1s ease-in;
 +
}
 +
 
 +
hr {
 +
    display: block;
 +
    height: 1px;
 +
    border: 0;
 +
    border-top: 1px solid #ccc;
 +
    margin: 1em 0;
 +
    padding: 0;
 +
}
 +
 
 +
.copyrights{
 +
text-indent:-9999px;
 +
height:0;
 +
line-height:0;
 +
font-size:0;
 +
overflow:hidden;
 +
}
 +
 
 +
.navbar {
 +
text-transform: uppercase;
 +
margin-bottom: 0px;
 +
}
 +
 
 +
.navbar-inverse {
 +
padding-bottom: 30px;
 +
padding-top: 0;
 +
}
 +
 
 +
.navbar-inverse {
 +
background-color: #FFA07A;
 +
border-color: #FA8072;
 +
}
 +
 
 +
.navbar-inverse .navbar-nav > li > a {
 +
color: white;
 +
 +
}
 +
 
 +
 
 +
.navbar-inverse .navbar-nav > li > a:hover {
 +
color: #222222;
 +
}
 +
 
 +
.navbar-brand {
 +
font-weight: 700;
 +
font-size: 40px;
 +
letter-spacing: 2px;
 +
backgroud: white;
 +
}
 +
 
 +
.navbar-inverse .navbar-brand {
 +
color: white;
 +
background-color: #FFA07A;
 +
 +
}
 +
 
 +
.navbar-inverse .navbar-toggle {
 +
border-color: transparent;
 +
font-size: 12px;
 +
}
 +
 
 +
.progress-bar-theme {
 +
  background-color: #FFA07A;
 +
}
 +
 
 +
 
 +
/* Helpers */
 +
 
 +
.mt {
 +
margin-top: 40px;
 +
margin-bottom: 40px;
 +
}
 +
 
 +
.pt {
 +
padding-top: 50px;
 +
padding-bottom: 50px;
 +
}
 +
 
 +
 
 +
/* +++++ WRAP SECTIONS +++++ */
 +
 
 +
#ww {
 +
padding-top: 0px;
 +
padding-bottom: 70px;
 +
background-color: #f2f2f2;
 +
}
 +
 
 +
 
 +
 
 +
/* ================== PORTFOLIO IMAGES HOVER EFFECT ================== */
 +
/* Effects also are controled by hover.zoom.js */
 +
.zoom {
 +
    display:block;
 +
    position:relative;
 +
    overflow:hidden;
 +
    background:transparent url(https://static.igem.org/mediawiki/2017/f/fe/Bgic_loader.gif) no-repeat center;
 +
}
 +
 
 +
 
 +
    .zoomOverlay {
 +
        position:absolute;
 +
        top:0; left:0;
 +
        bottom:0; right:0;
 +
        display:none;
 +
        background-image:url(../img/zoom.png);
 +
        background-repeat:no-repeat;
 +
        background-position:center;
 +
    }
 +
 
 +
.zoom2 {
 +
opacity: 1;
 +
}
 +
 
 +
.zoom2:hover {
 +
opacity: 0.5;
 +
}
 +
 
 +
 
 +
  </style>
 
    
 
    
 
   <!-- script -->
 
   <!-- script -->
 
   <script src="https://code.jquery.com/jquery-1.10.2.min.js"></script>
 
   <script src="https://code.jquery.com/jquery-1.10.2.min.js"></script>
  <script src="https://2017.igem.org/Team:BGIC-Union/jeasing-js?action=raw&amp;ctype=text/javascript"></script>
+
 
 
   <script src="https://2017.igem.org/Template:BGIC-Union/newbootstrap-js?action=raw&amp;ctype=text/javascript"></script>
 
   <script src="https://2017.igem.org/Template:BGIC-Union/newbootstrap-js?action=raw&amp;ctype=text/javascript"></script>
  <!-- SLIDER_TIMELINE -->
 
<script type="text/javascript" src="https://2017.igem.org/Template:BGIC-Union/timeline-js?action=raw&amp;ctype=text/javascript"></script>
 
<script type="text/javascript">
 
  
$(window).load(function() {
 
// dark
 
$('.timelineLight').timeline({
 
openTriggerClass : '.read_more',
 
startItem : '15/08/2012'
 
});
 
});
 
</script>
 
 
  <!-- hover    -->   
 
  <!-- hover    -->   
 
   <script src="https://2017.igem.org/Template:BGIC-Union/hovernew-js?action=raw&amp;ctype=text/javascript"></script>
 
   <script src="https://2017.igem.org/Template:BGIC-Union/hovernew-js?action=raw&amp;ctype=text/javascript"></script>
Line 69: Line 247:
 
   </head>
 
   </head>
  
  <body>
+
 
 +
<body>
 
<div class="column_full_size top1">
 
<div class="column_full_size top1">
 
<nav class="navbar navbar-inverse navbar-static-top" role="navigation">
 
<nav class="navbar navbar-inverse navbar-static-top" role="navigation">
Line 87: Line 266:
 
                     <li><a href="https://2017.igem.org/Team:BGIC-Union/Team">members</a></li>
 
                     <li><a href="https://2017.igem.org/Team:BGIC-Union/Team">members</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Collaborations">collaborations</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Collaborations">collaborations</a></li>
<li><a href="https://2017.igem.org/Team:BGIC-Union/Sponsors">sponsors</a></li>
+
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Attributions">attributions</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Attributions">attributions</a></li>
 
                             </ul>
 
                             </ul>
Line 99: Line 278:
 
                             <ul class="dropdown-menu" >
 
                             <ul class="dropdown-menu" >
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Description">description</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Description">description</a></li>
<li><a href="https://2017.igem.org/Team:BGIC-Union/Design”></a>design</li>
+
<li><a href="https://2017.igem.org/Team:BGIC-Union/Design">design</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Results">results</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Results">results</a></li>
                                <li><a href="https://2017.igem.org/Team:BGIC-Union/Model">model</a></li>
+
                         
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Demonstrate">demonstrate</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Demonstrate">demonstrate</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Improve">improve</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Improve">improve</a></li>
 +
<li><a href="https://2017.igem.org/Team:BGIC-Union/References">references</a></li>
 
                             </ul>
 
                             </ul>
 
                         </li>
 
                         </li>
Line 110: Line 290:
 
                         <li class="dropdown ">    <a href="https://2017.igem.org/Team:BGIC-Union/Lab" class="dropdown-toggle" data-toggle="dropdown"> <b class="caret"></b></a>
 
                         <li class="dropdown ">    <a href="https://2017.igem.org/Team:BGIC-Union/Lab" class="dropdown-toggle" data-toggle="dropdown"> <b class="caret"></b></a>
 
                             <ul class="dropdown-menu" role="menu">
 
                             <ul class="dropdown-menu" role="menu">
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Experiments">experiments</a></li>
+
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Experiments">protocols</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Notebook">notebook</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:BGIC-Union/Notebook">notebook</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/InterLab">InterLab</a></li></ul>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/InterLab">InterLab</a></li></ul>
Line 122: Line 302:
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Composite_Parts">composite parts</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Composite_Parts">composite parts</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Parts_Collection">parts collection</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Parts_Collection">parts collection</a></li>
<li><a href="https://2017.igem.org/Team:BGIC-Union/Measurement">measurement</a></li>
+
 
  
 
                             </ul>
 
                             </ul>
Line 130: Line 310:
 
                           <li class="dropdown ">  <a href="https://2017.igem.org/Team:BGIC-Union/Practices-Design" class="dropdown-toggle" data-toggle="dropdown"> <b class="caret"></b></a>
 
                           <li class="dropdown ">  <a href="https://2017.igem.org/Team:BGIC-Union/Practices-Design" class="dropdown-toggle" data-toggle="dropdown"> <b class="caret"></b></a>
 
                             <ul class="dropdown-menu" role="menu">
 
                             <ul class="dropdown-menu" role="menu">
                                                              <li><a href="https://2017.igem.org/Team:BGIC-Union/HP/Silver">silver</a></li>
+
                             
<li><a href="https://2017.igem.org/Team:BGIC-Union/HP/Gold_Integrated">Gold</a></li>
+
                                <li><a href="https://2017.igem.org/Team:BGIC-Union/HP/Silver">silver</a></li>
 +
<li><a href="https://2017.igem.org/Team:BGIC-Union/HP/Gold_Integrated">gold</a></li>
 +
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Engagement">public engagement</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Engagement">public engagement</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Applied_Design">applied design</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Applied_Design">applied design</a></li>
Line 137: Line 319:
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Entrepreneurship">entrepreneurship</a></li>
 
<li><a href="https://2017.igem.org/Team:BGIC-Union/Entrepreneurship">entrepreneurship</a></li>
 
                             </ul>
 
                             </ul>
 +
                        </li>
 +
<li class="dropdown ">
 +
                            <a href="https://2017.igem.org/Team:BGIC-Union/Model">Model </a>
 
                         </li>
 
                         </li>
 
<li class="dropdown ">
 
<li class="dropdown ">
Line 147: Line 332:
 
     </div>
 
     </div>
 
     </div>
 
     </div>
</nav> <!-- Slider start -->
+
</nav>
   
+
   
 
+
<!-- Slider start -->
+
  <!-- Slider start -->
+
</div>
    <section >
+
 +
  <section >
 
         <div class="carousel slide" id="carousel-example-generic" data-ride="carousel">
 
         <div class="carousel slide" id="carousel-example-generic" data-ride="carousel">
 
            
 
            
Line 159: Line 345:
 
           <div class="item active">
 
           <div class="item active">
 
           <div class="overlay-slide">
 
           <div class="overlay-slide">
           <img src="https://static.igem.org/mediawiki/2017/8/89/P3%21%21%21.jpg" class="img-responsive">
+
           <img src="https://static.igem.org/mediawiki/2017/archive/8/89/20171021063547%21P3%21%21%21.jpg" width="1300px" class="img-responsive">
 
           </div>
 
           </div>
 
           <div class="carousel-caption">
 
           <div class="carousel-caption">
 
               <div class="col-md-12 col-xs-12 text-center">
 
               <div class="col-md-12 col-xs-12 text-center">
                       <h2>dCasentry</h2>
+
                       <h1>dCasentry</h1>
 
               <h3 class="animated2">a <b>dCas9-T7</b>coupled DNA sensor </h3>
 
               <h3 class="animated2">a <b>dCas9-T7</b>coupled DNA sensor </h3>
 
               <div class="line"></div>
 
               <div class="line"></div>
Line 187: Line 373:
 
</div>
 
</div>
 
</div><h1 class="center">Hi, I am dCasentry,</h1>
 
</div><h1 class="center">Hi, I am dCasentry,</h1>
<div>a T7—dCas9 multi-output DNA sensor designed to detect ctDNA!</h2>
+
<div class="row">
Cancer is a leading cause of death worldwide, accounting for 8.8 million deaths in 2015, and the most common cause of cancer death is lung cancer (1.69 million deaths). Nowadays, multiple lung cancer detection methods are developed, one of them being liquid biopsy. The technique of liquid biopsy is much better than the popular biopsy as it obviates pain and complication incurred to patients by detecting various tumor markup, including short strand circulating tumor DNA (CtDNA) in the blood. However, it still requires laboratory apparatus such as PCR instrument.
+
<div class="col-md-6">
 +
<div>dCasentry: A guardian against Lung Cancer</br>
 +
Lung cancer is one of the deadliest malignant tumors in the world, with highest death rate in China. The most widely used lung cancer detection method nowadays remains biopsy, which may cause pain infection and bruising. However, the technic of liquid biopsy obviates this problem by detecting various factors including circulating tumor DNA (ctDNA) in the blood. ctDNA is a short strand of DNA released from tumor cells that can be deemed as the sign of cancer. Although traditional liquid biopsy avoids many side effects, it requires laboratory apparatus such as PCR instrument during detection. Also, some other ctDNA detection systems fail to overcome the difficulty of the extremely low concentration of ctDNA in the blood. To solve those problems, we developed a new liquid biopsy method using dCas9 protein with a much simple procedure while increase the signal with various kinds of output. We hope to adopt free-dried paper chip as our vector of detecting system to simplify its operation as well as storage. Finally, the product will be presented as a kit that contains all the items you needed for convenient machine-free detection.
 
</br>
 
</br>
Thus our primary task is to devise a more efficient, rapid and convenient lung cancer prognosis method. We construct a paper chip containing powerful biosensor capable of detecting the fusion gene, EML4-ALK, which only exists only in NSCLC (non small cell lung cancer) patients’ blood. Specific targeted drug for this mutation has been produced, which means patients can receive precise treatment as soon as possible when the detection result is positive. </br>
+
<i>Please, click <a href="https://2017.igem.org/Team:BGIC-Union/Project">  here </a> and know more about me as well as the product!</i> </div>
+
</div>
The biosensor, dCasentry, consists of paired dCas9 protein guided by sgRNA and linked with split T7 RNA polymerase that serves as a switch. When the targeting lung cancer mutation gene is detected, visible signal will be released as the T7 RNA polymerase starts transcription. DCasentry not only deals with low ctDNA concentration in blood but also capable of producing various kinds of signal output, such as GFP and RFP.
+
<div class="col-md-6">
</br>
+
<img src="https://static.igem.org/mediawiki/2017/7/79/FigureDemo.jpg" width="500px" /></div></div><!-- /col-lg-8 -->
+
We adopt freeze-dried paper chip as the vector of the detection system to simplify its operation as well as storage. The DNA device and proteins needed for detection are mixed with cell-free system and freeze-dried on the paper chip. During testing, the blood sample of the patient provides a liquid environment to reactivate the cell-free system. The product will be presented as a kit, containing including hemostix, a hand power centrifuge, NASBA reaction system and the paper screening chip, that can be widely used on the medical field.
+
<p>Please, click <a href="https://2017.igem.org/Team:BGIC-Union/Project">  here </a> and know more about me as well as the product!</p>
+
</div><!-- /col-lg-8 -->
+
 
</div><!-- /row -->
 
</div><!-- /row -->
 
    </div> <!-- /container -->
 
    </div> <!-- /container -->
Line 236: Line 420:
 
 
 
 
<!-- +++++ Footer Section +++++ -->
 
 
 
<div id="footer">
 
<div class="container">
 
<div class="row">
 
<div class="col-lg-4">
 
    <p>F12 BGI-College,146 Beishan Road,Yantian District 518083
 
                                    </br> Shenzhen,Guangdong Province, China,Asia
 
                                </br>Phone:+86-755-36307888
 
                                </br>Email: info@genomics.cn
 
</br>Fax:+86-755-36307273</p>
 
</p>
 
</div><!-- /col-lg-4 -->
 
 
<div class="col-lg-4">
 
 
<p>
 
 
<a href="https://2017.igem.org/Team:BGIC-Union/Applied_Design">Applied Design</a><br/>
 
<a href="https://2017.igem.org/Team:BGIC-Union/Entrepreneurship">Entreprenuership</a><br/>
 
<a href="https://2017.igem.org/Team:BGIC-Union/Gold_Integrated">Integrated HP</a><br/>
 
                      <a href="https://2017.igem.org/Team:BGIC-Union/Engagement">Education & Public Engagement</a><br/>
 
  <a href="https://2017.igem.org/Team:BGIC-Union/Model">Model</a><br/>
 
<a href="https://2017.igem.org/Team:BGIC-Union/Evaluation">EVALUATION</a>
 
</p>
 
</div><!-- /col-lg-4 -->
 
 
<div class="col-lg-4">
 
<h4>BGIC-COLLEGE 2017</h4>
 
<img src="https://static.igem.org/mediawiki/2017/d/de/Repute-logo-light.png" width="60px" height="72px"></img>
 
<p></br><i class="fa-twitter">TWITTER:@BGIC-Union</i> </p>
 
 
</div><!-- /col-lg-4 -->
 
 
</div>
 
 
</div>
 
</div>
 
 
</div>
 
</div>
  

Latest revision as of 13:11, 2 December 2017

Team:BGIC-Union

Hi, I am dCasentry,

dCasentry: A guardian against Lung Cancer
Lung cancer is one of the deadliest malignant tumors in the world, with highest death rate in China. The most widely used lung cancer detection method nowadays remains biopsy, which may cause pain infection and bruising. However, the technic of liquid biopsy obviates this problem by detecting various factors including circulating tumor DNA (ctDNA) in the blood. ctDNA is a short strand of DNA released from tumor cells that can be deemed as the sign of cancer. Although traditional liquid biopsy avoids many side effects, it requires laboratory apparatus such as PCR instrument during detection. Also, some other ctDNA detection systems fail to overcome the difficulty of the extremely low concentration of ctDNA in the blood. To solve those problems, we developed a new liquid biopsy method using dCas9 protein with a much simple procedure while increase the signal with various kinds of output. We hope to adopt free-dried paper chip as our vector of detecting system to simplify its operation as well as storage. Finally, the product will be presented as a kit that contains all the items you needed for convenient machine-free detection.
Please, click here and know more about me as well as the product!